Editorial discusses what can be done if the specialty societies and other organisations that prepare clinical practice guidelines are unwilling or unable to improve their performance in disclosing, managing, and eliminating financial conflicts of interest. It notes that this remains an intractable problem in the US, and improvement is unlikely without decisive actions. Unfortunately, many of the professional societies that convene panels to develop practice guidelines have financial conflicts of interest with industry themselves.